Supportive Care in Head and Neck Cancers: Multidisciplinary Management

Presented by:
Jimmy J. Caudell
Search for other papers by Jimmy J. Caudell in
Current site
Google Scholar
PubMed Close
 MD, PhD
,
David G. Pfister
Search for other papers by David G. Pfister in
Current site
Google Scholar
PubMed Close
 MD
, and
Randal S. Weber
Search for other papers by Randal S. Weber in
Current site
Google Scholar
PubMed Close
 MD
Volume/Issue:
Volume 19: Issue 5.5
Online Publication Date:
17 May 2021
DOI:
https://doi.org/10.6004/jnccn.2021.5010
Restricted access

Patients with head and neck cancer experience a broad array of negative quality-of-life issues, but particularly common are dental complications following radiation therapy, and compromised nutrition with significant weight loss. At the NCCN 2021 Virtual Annual Conference, a panel of experts used a case-based approach to discuss some of these common adverse effects of head and neck cancer and its treatment, as well as optimal supportive care strategies to manage them.

Disclosures: Dr. Caudell has disclosed receiving grant/research support from Varian Medical Systems, Inc. Dr. Pfister has disclosed receiving grant/research support from Atara Biotherapeutics and Merck & Co., Inc. Dr. Weber has disclosed no relevant financial relationships.

Correspondence: Jimmy J. Caudell, MD, PhD, Moffitt Cancer Center, Department of Radiation Oncology, 12902 Magnolia Drive, Tampa, FL 33612. Email: jimmy.caudell@moffitt.org; David G. Pfister, MD, Memorial Sloan Kettering Cancer Center, 530 East 74th Street, New York, NY 10021. Email: pfisterd@mskcc.org; and Randal S. Weber, MD, The University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery, 1400 Pressler Street, Unit 1445, Houston, TX 77030. Email: rsweber@mdanderson.org
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
  • 1.

    Siegel RL, Miller KD, Jemal A, et al. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7–34.

  • 2.

    Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127–136.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Jha N, Harris J, Seikaly H, et al. A phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in head-and-neck cancer (RTOG 0244). Int J Radiat Oncol Biol Phys 2012;84:437–442.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000;18:3339–3345.

  • 5.

    Jaguar GC, Lima ENP, Kowalski LP, et al. Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients. Radiother Oncol 2015;115:253–256.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Chambers MS, Posner M, Jones CU, et al. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007;68:1102–1109.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Pfister DG, Cassileth BR, Deng GE, et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol 2010;28:2565–2670.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Forner L, Hyldegaard O, von Brockdorff AS, et al. Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study. Oral Oncol 2011;47:546–551.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Chow JCH, Cheung K, Au K, et al. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: clinical predictors and dose-toxicity relationship. Radiother Oncol 2019;138:93–98.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Aggarwal P, Goepfert R, Garden AS, et al. Risk and clinical risk factors associated with late lower cranial neuropathy in long-term oropharyngeal squamous cell carcinoma survivors [published online February 4, 2021]. JAMA Otolaryngol Head Neck Surg, doi: 10.1001/jamaoto.2020.5269

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Page Numbers:
4
Article Category:
Research Article
Print Publication Date:
01 May 2021
Online Publication Date:
17 May 2021

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 2492 344 33
PDF Downloads 1217 205 22
EPUB Downloads 0 0 0